The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 23, 2022

Filed:

Aug. 17, 2018
Applicant:

Conopco, Inc., Englewood Cliffs, NJ (US);

Inventors:

Chenliang Guo, Shanghai, CN;

Nan Huang, Shanghai, CN;

Sheila Alves Rocha, Bogota, NJ (US);

Assignee:

CONOPCO, INC., Englewood Cliffs, NJ (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 8/36 (2006.01); A61K 8/9778 (2017.01); A61K 8/34 (2006.01); A61K 8/37 (2006.01); A61K 8/42 (2006.01); A61K 8/67 (2006.01); A61Q 5/00 (2006.01); A61Q 11/00 (2006.01); A61Q 19/08 (2006.01);
U.S. Cl.
CPC ...
A61K 8/361 (2013.01); A61K 8/347 (2013.01); A61K 8/37 (2013.01); A61K 8/42 (2013.01); A61K 8/676 (2013.01); A61K 8/9778 (2017.08); A61Q 5/00 (2013.01); A61Q 11/00 (2013.01); A61Q 19/08 (2013.01); A61K 2800/59 (2013.01); A61K 2800/92 (2013.01);
Abstract

The invention relates to a personal care composition, more particularly to a composition for application to a topical surface that prevents or reduces inflammation. The composition could be delivered in the form of a skin, scalp, hair or oral care product, more particularly a skin care product. The benefit is delivered via a combination of a polyunsaturated fatty acid (PUFA) or ester thereof selected from docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), DHA-ethyl ester, EPA-ethyl ester, DHA-triglyceride, EPA-triglyceride, dihomogamma-Linolenic Acid (DGLA), DGLA-ethyl ester, DGLA-triglyceride or combinations thereof and a 4-substituted resorcinol compound, wherein the mole ratio of the PUFA or ester thereof to the 4-substituted resorcinol compound is 5:1 to 1:5.


Find Patent Forward Citations

Loading…